The Effect of Statin Added to Systemic Anticancer Therapy: A Meta-Analysis of Randomized, Controlled Trials

Statin Use After Diagnosis of Colon Cancer and Patient Survival

(2017) Philip W. Voorneveld et al.   GASTROENTEROLOGY

Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)

(2017) Michael J. Seckl et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer

(2017) Youngjoo Lee et al.   Cancer Research and Treatment

Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study

(2016) Leo Alexandre et al.   GASTROENTEROLOGY

Simvastatin Induces Apoptosis and Suppresses Insulin-Like Growth Factor 1 Receptor in Bile Duct Cancer Cells

(2016) Jin Lee et al.   Gut and Liver

Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis

(2016) Sashidhar Manthravadi et al.   INTERNATIONAL JOURNAL OF CANCER

Statin induces apoptosis of human colon cancer cells and downregulation of insulin-like growth factor 1 receptor via proapoptotic ERK activation

(2016) HYUN JOO JANG et al.   Oncology Letters

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer

(2015) S H Lim et al.   BRITISH JOURNAL OF CANCER

Statin Use and Survival from Lung Cancer: A Population-Based Cohort Study

(2015) C. R. Cardwell et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies

(2015) Shanliang Zhong et al.   CANCER TREATMENT REVIEWS

Presentation of meta-analysis plots

(2015) NJ Wald et al.   JOURNAL OF MEDICAL SCREENING

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

(2015)   LANCET

Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation

(2015) Ondrej Fiala et al.   TUMOR BIOLOGY

Simvastatin plus capecitabine–cisplatin versus placebo plus capecitabine–cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study

(2014) Seung Tae Kim et al.   EUROPEAN JOURNAL OF CANCER

Statin Use After Colorectal Cancer Diagnosis and Survival: A Population-Based Cohort Study

(2014) Chris R. Cardwell et al.   JOURNAL OF CLINICAL ONCOLOGY

Statin Use Is Not Associated with Improved Progression Free Survival in Cetuximab Treated KRAS Mutant Metastatic Colorectal Cancer Patients: Results from the CAIRO2 Study

(2014) Lisanne L. Krens et al.   PLoS One

Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients

(2013) Jung Yong Hong et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Statins and the Risk of Lung Cancer: A Meta-Analysis

(2013) Min Tan et al.   PLoS One

Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses

(2013) Nikola Panic et al.   PLoS One

Metformin and the Risk of Cancer: Time-related biases in observational studies

(2012) S. Suissa et al.   DIABETES CARE

Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1

(2012) Jie Chen et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer

(2011) Ji-Youn Han et al.   CLINICAL CANCER RESEARCH

Effect of Simvastatin on Cetuximab Resistance in Human Colorectal Cancer With KRAS Mutations

(2011) Jeeyun Lee et al.   JNCI-Journal of the National Cancer Institute

Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation: Modulation of Molecular Pathways of Radioresistance and Tumor Suppression

(2011) Toran Sanli et al.   Journal of Thoracic Oncology

An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR-Dependent Pathway

(2011) D. Guo et al.   Cancer Discovery

A phase 2 study of irinotecan, cisplatin, and simvastatin for untreated extensive-disease small cell lung cancer

(2010) Ji-Youn Han et al.   CANCER

Therapeutic modulation of k-ras signaling in colorectal cancer

(2010) Lisanne L. Krens et al.   DRUG DISCOVERY TODAY

The addition of pravastatin to chemotherapy in advanced gastric carcinoma: A randomised phase II trial

(2010) Inge R.H.M. Konings et al.   EUROPEAN JOURNAL OF CANCER

Simvastatin enhances irinotecan-induced apoptosis in human non-small cell lung cancer cells by inhibition of proteasome activity

(2010) In Hae Park et al.   INVESTIGATIONAL NEW DRUGS

Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study

(2009) Jeeyun Lee et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: An updated meta-analysis

(2009) Philippa J. Delahoy et al.   CLINICAL THERAPEUTICS

Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations

(2009) In Hae Park et al.   INVESTIGATIONAL NEW DRUGS

Statins and cancer: A systematic review and meta-analysis

(2008) Jaana Kuoppala et al.   EUROPEAN JOURNAL OF CANCER

Statins for Secondary Prevention in Elderly Patients

(2008) Jonathan Afilalo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY